G. Defreyn

2.2k total citations
34 papers, 1.7k citations indexed

About

G. Defreyn is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, G. Defreyn has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 6 papers in Hematology. Recurrent topics in G. Defreyn's work include Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Biochemical and Molecular Research (7 papers) and Platelet Disorders and Treatments (4 papers). G. Defreyn is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Biochemical and Molecular Research (7 papers) and Platelet Disorders and Treatments (4 papers). G. Defreyn collaborates with scholars based in Belgium, France and United Kingdom. G. Defreyn's co-authors include S.J. Machin, Jos Vermylen, Jean‐Marc Herbert, Jean‐Pierre Maffrand, R DEMAN, Bernard Spitz, André Van Assche, L Carreras, J. Vermylen and Jozef Goris and has published in prestigious journals such as The Lancet, FEBS Letters and European Journal of Biochemistry.

In The Last Decade

G. Defreyn

34 papers receiving 1.6k citations

Peers

Countries citing papers authored by G. Defreyn

Since Specialization

Citations

This map shows the geographic impact of G. Defreyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Defreyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Defreyn more than expected).

Fields of papers citing papers by G. Defreyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Defreyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Defreyn. The network helps show where G. Defreyn may publish in the future.

Co-authorship network of co-authors of G. Defreyn

This figure shows the co-authorship network connecting the top 25 collaborators of G. Defreyn. A scholar is included among the top collaborators of G. Defreyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Defreyn. G. Defreyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ticlopidine Increases Nitric Oxide Generation in Heart-Transplant Recipients: A Possible Novel Property of Ticlopidine 1998 ·Journal of Cardiovascular Pharmacology ·M. de Lorgeril, Jean‐Claude Bordet, Patricia Salen, Shauna Durbin, G. Defreyn, J Delaye, P. Boissonnat	15
2	Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. 1993 ·Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·Jean‐Marc Herbert, (unknown), G. Defreyn, Jean‐Pierre Maffrand	92
3	Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent 1993 ·Cardiovascular Drug Reviews ·Jean‐Marc Herbert, D. FREHEL, E. Vallée, G Kieffer, D. Gouy, Yves Berger, J Necciari, G. Defreyn, Jean‐Pierre Maffrand	184
4	Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel 1992 ·Biochemical Pharmacology ·Pierre Savi, Jean‐Marc Herbert, (unknown), F. Dol, Denis Delebassée, Jean Combalbert, G. Defreyn, Jean‐Pierre Maffrand	161
5	Production and Evaluation of Recombinant Hirudin 1989 ·Seminars in Thrombosis and Hemostasis ·Michael Courtney, G. Loison, Yves Lemoine, (unknown), Eric Degryse, Stephen Brown, Jean‐Pierre Cazenave, G. Defreyn, Denis Delebassée, A. Bernat, J.P. Maffrand, Carolyn Roitsch	15
6	Point mutations modifying the thrombin inhibition kinetics and antithrombotic activity in vivo of recombinant hirudin 1989 ·Protein Engineering Design and Selection ·Eric Degryse, Michael Acker, G. Defreyn, A. Bernat, J.P. Maffrand, Carolyn Roitsch, Michael Courtney	34
7	Effect of PCR 4099 on ADP-induced calcium movements and phosphatidic acid production in rat platelets 1988 ·Biochemical Pharmacology ·(unknown), Marie‐Françoise Simon, Hugues Chap, L Douste-Blazy, G. Defreyn, Jean‐Pierre Maffrand	19
8	Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP 1987 ·Thrombosis Research ·(unknown), Denis Delebassée, Michel Simon, Hugues Chap, G. Defreyn, E. Vallée, Louis Douste‐Blazy, J.P. Maffrand	65
9	Antithrombotic activity of suloctidil 1983 ·Thrombosis Research ·J. Roba, G. Defreyn, G. Biagi	5
10	Low prostacyclin synthetase activity of fetal rat aorta. Progressive increase after birth. 1983 ·Life Sciences ·Hans Deckmyn, Laura Font, (unknown), L Carreras, G. Defreyn, Julia H. Vermylen	9
11	ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATION 1981 ·The Lancet ·L Carreras, S.J. Machin, R DEMAN, G. Defreyn, Jos Vermylen, Bernard Spitz, André Van Assche	428
12	The Effect of Clinical Prostacyclin Infusions in Advanced Arterial Disease on Platelet Function and Plasma 6‐keto PGF_1α Levels 1981 ·British Journal of Haematology ·S.J. Machin, Dalton A. F. Chamone, G. Defreyn, J. Vermylen	17
13	Familial Bleeding Tendency with Partial Platelet Thromboxane Synthetase Deficiency: Reorientation of Cyclic Endoperoxide Metabolism 1981 ·British Journal of Haematology ·G. Defreyn, S.J. Machin, L Carreras, (unknown), Dalton A. F. Chamone, J. Vermylen	47
14	A plasma factor in uraemia which stimulates prostacyclin release from cultured endothelial cells 1980 ·Thrombosis Research ·G. Defreyn, (unknown), S.J. Machin, Jos Vermylen	41
15	Resolution of the ATP‐Mg‐dependent phosphorylase phosphatase from liver into a two protein component system 1979 ·FEBS Letters ·Jozef Goris, G. Defreyn, Wilfried Merlevede	44
16	Characterization of the Phosphorylase Phosphatase associated with Dog Liver Particulate Glycogen as a Manganese Metalloenzyme 1979 ·Biochemical Society Transactions ·G. Defreyn, (unknown), Jozef Goris, R Lontie, Wilfried Merlevede	2
17	Inhibition of Liver Phosphorylase Phosphatase by Adenosine 3′:5′-Cyclic Monophosphate-Dependent and -Independent Protein Inhibitors 1977 ·Biochemical Society Transactions ·Jozef Goris, G. Defreyn, Wilfried Merlevede	7
18	A deinhibitor protein neutralizing the effect of the protein inhibitors on dog liver phosphorylase phosphatase 1977 ·FEBS Letters ·G. Defreyn, Jozef Goris, Wilfried Merlevede	27
19	Activation of dog liver phosphorylase phosphatase by ethanol and urea 1977 ·Archives Internationales de Physiologie et de Biochimie ·G. Defreyn, J. Goris, W. Merlevede	2
20	Regulation of glycogen phosphorylase phosphatase activity by ATP-Mg2+ and cyclic AMP. 1976 ·PubMed ·Wilfried Merlevede, G. Defreyn, Jozef Goris, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact